↓ Skip to main content

Antiepileptic drug monotherapy for epilepsy: a network meta‐analysis of individual participant data

Overview of attention for article published in Cochrane database of systematic reviews, April 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

blogs
2 blogs
twitter
42 X users
facebook
1 Facebook page
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
235 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antiepileptic drug monotherapy for epilepsy: a network meta‐analysis of individual participant data
Published in
Cochrane database of systematic reviews, April 2022
DOI 10.1002/14651858.cd011412.pub4
Pubmed ID
Authors

Sarah J Nevitt, Maria Sudell, Sofia Cividini, Anthony G Marson, Catrin Tudur Smith

X Demographics

X Demographics

The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 235 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 235 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 12%
Student > Bachelor 26 11%
Other 18 8%
Researcher 17 7%
Student > Ph. D. Student 14 6%
Other 41 17%
Unknown 90 38%
Readers by discipline Count As %
Medicine and Dentistry 53 23%
Nursing and Health Professions 18 8%
Biochemistry, Genetics and Molecular Biology 12 5%
Pharmacology, Toxicology and Pharmaceutical Science 10 4%
Psychology 9 4%
Other 37 16%
Unknown 96 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2023.
All research outputs
#1,049,048
of 25,707,225 outputs
Outputs from Cochrane database of systematic reviews
#2,089
of 13,138 outputs
Outputs of similar age
#25,644
of 449,250 outputs
Outputs of similar age from Cochrane database of systematic reviews
#26
of 120 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,138 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,250 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 120 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.